Subscribe To
Precipio continues to sign up and onboard HemeScreen™ customers
Conversion from sales funnels developed with distribution partners alongside direct sales points to continued accelerated growth NEW HAVEN, Conn., March 07, 2023 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) continues to convert its sales pipeline into HemeScreen customers, with an additional recently signed agreement expected to generate annualized revenues exceeding $125,000. Furthermore, this […] The post Precipio continues to sign up and onboard HemeSc...
Read More
Posted: Mar 7 2023, 17:00
Author Name: forextv
Views: 110790